Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Viruses
|
February 15, 2018
ALV Integration-Associated Hypomethylation at the TERT Promoter Locus
Gary Lam, Karen Beemon
Plos Pathogens
|
November 4, 2017
Selection for avian leukosis virus integration sites determines the clonal progression of B-cell lymphomas
Sanandan Malhotra, Shelby Winans, Gary Lam, et al.
Genes
|
October 30, 2016
Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma
Gary Lam, Rena R Xian, Yingying Li, et al.
Science Translational Medicine
|
August 23, 2013
Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy
Francesca Mascia, Gary Lam, Christopher Keith, et al.
The Protein Journal
|
November 15, 2006
The effects of removing the GAT domain from E. coli GMP synthetase
Jessica L Abbott, Jordan M Newell, Christine M Lightcap, et al.
Human Vaccines & Immunotherapeutics
|
December 18, 2024
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel
Bosco Paes, Vivien Brown, Erin Courtney, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Viruses
|
February 15, 2018
ALV Integration-Associated Hypomethylation at the TERT Promoter Locus
Gary Lam, Karen Beemon
Plos Pathogens
|
November 4, 2017
Selection for avian leukosis virus integration sites determines the clonal progression of B-cell lymphomas
Sanandan Malhotra, Shelby Winans, Gary Lam, et al.
Genes
|
October 30, 2016
Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma
Gary Lam, Rena R Xian, Yingying Li, et al.
Science Translational Medicine
|
August 23, 2013
Genetic ablation of epidermal EGFR reveals the dynamic origin of adverse effects of anti-EGFR therapy
Francesca Mascia, Gary Lam, Christopher Keith, et al.
The Protein Journal
|
November 15, 2006
The effects of removing the GAT domain from E. coli GMP synthetase
Jessica L Abbott, Jordan M Newell, Christine M Lightcap, et al.
Human Vaccines & Immunotherapeutics
|
December 18, 2024
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel
Bosco Paes, Vivien Brown, Erin Courtney, et al.
Page
of 1